As of midnight on
Chinese mainland reports
new infections of COVID-19 (including
imported cases) and
The overall confirmed cases on the Chinese mainland had reached
in serious condition
) still receiving medical treatment in hospital,
patients having been discharged after recovery, and
people died of the disease.
are expected to enter clinical trials soon, while
has been a priority in research and development.
The medicine named
has shown no obvious adverse reactions in the clinical trial. It can
shorten the recovery time
from 11 days to 4 days for mild and regular cases, and
shorten fever duration
from an averaged 4.2 days to 2.5 days.
, co-founder of Chinese online retail giant
, said on his
Through a donation of
testing kits and
masks, we join hands with Americans in these difficult times.